Verve Ventures is a Zug-based deep-tech investment firm that backs companies across health, bio, computing, and energy. It invests from seed through Series C and has become one of the more established multi-stage investors in the Swiss and DACH startup ecosystem. Its orientation is broad but clearly technology-centered.

Its health and bio portfolio includes diagnostics, therapies, digital health, and medtech, with neuro-relevant exposure such as Artiria Medical. Verve is not a pure neurotech specialist, but it is relevant to companies building technically differentiated healthcare platforms in Europe. Its multi-stage capacity and regional network make it useful for founders who want continuity beyond the earliest rounds.

The firm primarily invests across Switzerland, Germany, and wider Europe. For neurotech founders, it is most relevant in the European deep-tech and medtech context, particularly for companies with device, diagnostics, or intervention-related angles. It is a strong regional deep-tech fund with selective neuro relevance.